DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,109 filers reported holding DANAHER CORPORATION in Q4 2016. The put-call ratio across all filers is 0.26 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $13,561,000 | -3.3% | 88,359 | -9.0% | 1.35% | +8.8% |
| Q3 2019 | $14,026,000 | +52.4% | 97,112 | +50.8% | 1.24% | +42.2% |
| Q2 2019 | $9,206,000 | +215.6% | 64,412 | +88.8% | 0.88% | +226.5% |
| Q1 2017 | $2,917,000 | -84.7% | 34,110 | -86.0% | 0.27% | -80.4% |
| Q4 2016 | $19,006,000 | +59.5% | 244,164 | +60.6% | 1.36% | +41.0% |
| Q3 2016 | $11,915,000 | -31.3% | 152,000 | -18.6% | 0.97% | +11.8% |
| Q4 2015 | $17,338,000 | -46.4% | 186,675 | -50.9% | 0.87% | -38.2% |
| Q3 2015 | $32,367,000 | +6.7% | 379,855 | +7.2% | 1.40% | -16.2% |
| Q2 2015 | $30,330,000 | +73.4% | 354,364 | +72.0% | 1.67% | +128.7% |
| Q1 2015 | $17,487,000 | +4.1% | 205,970 | +5.1% | 0.73% | +1.4% |
| Q4 2014 | $16,797,000 | +87.4% | 195,970 | +68.8% | 0.72% | +119.5% |
| Q4 2013 | $8,961,000 | +7.7% | 116,070 | -3.3% | 0.33% | -2.4% |
| Q3 2013 | $8,318,000 | -58.9% | 120,000 | -62.5% | 0.34% | -58.8% |
| Q2 2013 | $20,257,000 | – | 320,015 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |